UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (132) 132
humans (130) 130
life sciences & biomedicine (125) 125
female (97) 97
male (89) 89
adult (60) 60
middle aged (56) 56
life sciences (52) 52
biological and medical sciences (50) 50
medical sciences (46) 46
aged (37) 37
adolescent (36) 36
hematology (31) 31
abridged index medicus (28) 28
oncology (28) 28
prognosis (26) 26
prospective studies (24) 24
immunology (23) 23
child (22) 22
animals (21) 21
mutation (21) 21
young adult (21) 21
aged, 80 and over (19) 19
retrospective studies (19) 19
treatment outcome (19) 19
france (18) 18
research (18) 18
[sdv.can]life sciences [q-bio]/cancer (17) 17
cancer (16) 16
mice (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
child, preschool (15) 15
hematologic and hematopoietic diseases (15) 15
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (15) 15
health technology assessment (14) 14
risk factors (14) 14
gene expression (13) 13
infectious diseases (13) 13
internet (13) 13
[ sdv.can ] life sciences [q-bio]/cancer (12) 12
[sdv]life sciences [q-bio] (12) 12
doxorubicin - administration & dosage (12) 12
follow-up studies (12) 12
genetic aspects (12) 12
genomics (12) 12
human health and pathology (12) 12
infant (12) 12
lymphoma, large b-cell, diffuse - drug therapy (12) 12
analysis (11) 11
chemotherapy (11) 11
lymphoma, large b-cell, diffuse - genetics (11) 11
biochemistry, molecular biology (10) 10
care and treatment (10) 10
end-stage renal disease (10) 10
fundamental and applied biological sciences. psychology (10) 10
genetics (10) 10
microbiology (10) 10
multivariate analysis (10) 10
patients (10) 10
pharmacology. drug treatments (10) 10
rituximab (10) 10
survival analysis (10) 10
tumors (10) 10
cohort studies (9) 9
combined modality therapy (9) 9
general & internal medicine (9) 9
infant, newborn (9) 9
medicine (9) 9
pregnancy (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
gene expression profiling (8) 8
genes (8) 8
genotype (8) 8
hodgkin disease - drug therapy (8) 8
hodgkin disease - radiotherapy (8) 8
lymphoma, large b-cell, diffuse - mortality (8) 8
lymphomas (8) 8
mutation - genetics (8) 8
prednisone - administration & dosage (8) 8
diagnosis (7) 7
disease-free survival (7) 7
doxorubicin - therapeutic use (7) 7
france - epidemiology (7) 7
genetics & heredity (7) 7
hemic and lymphatic diseases (7) 7
hodgkin lymphoma (7) 7
kaplan-meier estimate (7) 7
kidney failure, chronic (7) 7
mesh: humans (7) 7
multidisciplinary sciences (7) 7
pathology (7) 7
patient outcomes (7) 7
pediatrics (7) 7
phenotype (7) 7
predictive value of tests (7) 7
science & technology - other topics (7) 7
studies (7) 7
transplantation (7) 7
urology & nephrology (7) 7
vincristine - administration & dosage (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human mutation, ISSN 1059-7794, 01/2013, Volume 34, Issue 1, pp. 83 - 87
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9806, pp. 1858 - 1867
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 549 - 561
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 07/2017, Volume 65, Issue 2, pp. 282 - 291
Journal Article